Allon Therapeutics Inc.

Situation:

Allon Therapeutics Inc., an early stage biotech company, wanted to raise awareness of its company and neurodegenerative drugs with potential investors and the media.

Objective:

Epic PR was retained to elevate Allon Therapeutics’ profile and attract new investors.

Solution:

We executed a series of media briefings with key business media in Toronto and Vancouver so that the company would be well positioned for future coverage about the company’s progress. To further celebrate the debut, we organized launch events in both Toronto and Vancouver, inviting key stakeholders. Following Allon’s listing on the TSX, Epic PR oversaw corporate communications and investor relations activities for the company, which included press releases, investor conferences & presentations, website management and communication materials development.

Results:

Epic PR’s media outreach garnered extensive media coverage that culminated in a front page story in the business section of Vancouver’s largest newspaper as well as several wire and trade journal stories. Each event resulted in excellent attendance of influential stakeholders and potential shareholders. The company’s profile was elevated to new heights, with the stock price experiencing its largest increase ever during the proactive publicity campaign.